ArticleJournal of managed care & specialty pharmacy2023

Budget impact of oral nirmatrelvir/ritonavir in adults at high risk for progression to severe COVID-19 in the United States.

Rickard Sandin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.